Adverum Biotechnologies (ADVM)
4.36
+0.00%
Adverum Biotechnologies (ADVM) is currently trading at $4.36. This represents a gain of 0% from the previous session. With a market capitalization of $0.10B, ADVM is a key component of the Health Care sector. Investors looking to trade ADVM should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ADVM commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Adverum Biotechnologies (ADVM) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap0.10B
P/E Ratio0.0000
Volume0
60-Day Technical Chart
Advanced Charting
Need more indicators for ADVM? Use the world's #1 platform.
Open ADVM on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $4
| Metric |
ADVM +0.00% |
RXRX +11.05% |
IOVA +11.51% |
BBAI +1.92% |
|---|---|---|---|---|
| Price | $4.36 | $3.93 | $4.24 | $3.98 |
| Mkt Cap | $0.10B | $2.06B | $1.66B | $1.75B |
| - | View → | View → | View → |
Latest Headlines
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
Business Wire • Oct 27, 2025
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly
GlobeNewswire • Dec 1, 2025
After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain
simplywall.st • Oct 3, 2025
Adverum stock soars after Lilly announces acquisition deal
Investing.com • Oct 24, 2025
Adverum Biotechnologies Stock (ADVM) Opinions on Lilly Acquisition
Quiver Quantitative • Dec 9, 2025
● Gemini Agentic AI Analyst Insight for ADVM
Market Education
- Canada Pension Plan - Top Stocks Nov 20, 2023
- Stocks with Cash and Low Debt Dec 10, 2023
- Finding Stocks in the Squeeze Zone: Using Finviz Jul 30, 2023
External Research